Target-antigen expression, e.g., EGFR expression, on normal urothelial or peri-tumoral cells raises the possibility of off-tumor conjugate binding, resulting in unintended tissue injury when PIT triggers cytotoxicity. This evidence concerns the gene EGFR and neoplasm.